NeuroTherm Acquires Smith & Nephew Interventional Spine Pain Management

    Purchase further expands NeuroTherm's reach into the $5 Billion Global
    Interventional Pain Medicine Market

<p><span class="xn-location">WILMINGTON</span>, Mass., <span class="xn-chron">April 7</span> /CNW/ -- NeuroTherm announced today that they have acquired the Smith & Nephew PLC (NYSE:   SNN; LSE: SN) Interventional Spine Pain Management assets from Smith & Nephew's subsidiaries.  The acquired product line includes several innovative interventional spine pain products including the CDS Discography System, SPINECATH(TM) & ACUTHERM(TM) Catheters and a full radiofrequency product line.  NeuroTherm will also be a distributor of the TRUCATH(TM) Injection System within the Interventional Spine Pain market.</p>
<p>To view the multimedia assets associated with this release, please click <a href=""></a> entional-spine-pain-management-assets-89991457.html</p>

    (Logo: )

<p>"This acquisition made perfect sense for us, and will go a long way towards sustaining NeuroTherm's leading position in the interventional pain space," says <span class="xn-person">Larry Hicks</span>, President & CEO of NeuroTherm.  "The Smith & Nephew product line is highly complementary to ours and significantly expands our product offering.  This is an exciting opportunity that will enable us to offer a one-stop option for our customers," continues Hicks.</p>
<p>"We have set plans in place to combine the experience and product knowledge of the two worldwide sales teams to allow us to provide our global customer base with excellent products and a single point of contact," says Jos Kerstens, VP of International Sales.  NeuroTherm actively sells interventional pain products into 58 countries around the world.  "We remain focused on helping physicians expand their practice and offer improved patient care to patients who suffer from chronic pain," continues Kerstens.</p>
<p>NeuroTherm is a leading manufacturer of products used in the field of Interventional Pain, including radio frequency generators and related consumables used to treat chronic pain.  The company was awarded a US Patent #7,574,257 in recognition of the first multi-lesion radiofrequency generator launch.  NeuroTherm markets and sells to Interventional Pain, Interventional Radiology, Orthopedic and Foot & Ankle Specialists. Foot & Ankle Physicians use radiofrequency to treat pain associated with Plantar Fasciitis & Neuroma.</p>
<p>NeuroTherm is headquartered in <span class="xn-location">Wilmington</span>, Massachusetts with corporate offices in <span class="xn-location">London</span> and <span class="xn-location">Amsterdam</span>.  Additional information about NeuroTherm can be found on at <a href=""></a></p>
<p>Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management.  Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives.  The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust.  The Company operates in 32 countries around the world. Annual sales in 2009 were <span class="xn-money">$3.8 billion</span>.</p>


For further information: For further information: Toni Fournier, V.P. Marketing, +1-978-436-4336, Web Site:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890